ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 23 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8 | -33.3% | 36,461 | 0.0% | 0.00% | – |
| Q1 2023 | $12 | +71.4% | 36,461 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 36,461 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | -75.0% | 36,461 | 0.0% | 0.00% | – |
| Q2 2022 | $48,000 | -34.2% | 36,461 | 0.0% | 0.00% | – |
| Q1 2022 | $73,000 | -25.5% | 36,461 | 0.0% | 0.00% | – |
| Q4 2021 | $98,000 | -37.2% | 36,461 | 0.0% | 0.00% | – |
| Q3 2021 | $156,000 | +110.8% | 36,461 | +25.5% | 0.00% | – |
| Q2 2021 | $74,000 | +39.6% | 29,050 | +31.7% | 0.00% | – |
| Q1 2021 | $53,000 | +194.4% | 22,050 | +107.3% | 0.00% | – |
| Q4 2020 | $18,000 | -21.7% | 10,635 | 0.0% | 0.00% | – |
| Q3 2020 | $23,000 | +64.3% | 10,635 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +7.7% | 10,635 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -48.0% | 10,635 | 0.0% | 0.00% | – |
| Q4 2019 | $25,000 | +56.2% | 10,635 | 0.0% | 0.00% | – |
| Q3 2019 | $16,000 | – | 10,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,817,454 | $3,653,000 | 0.07% |
| CSS LLC/IL | 41,300 | $83,000 | 0.00% |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 35,000 | $70,000 | 0.00% |
| CSS LLC/IL | 33,900 | $68,000 | 0.00% |
| Private Advisor Group, LLC | 34,150 | $69,000 | 0.00% |
| OPPENHEIMER & CO INC | 38,500 | $77,000 | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 590,852 | $1,187,000 | 0.00% |
| UBS Group AG | 6,840 | $14,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 8,321 | $25,000 | 0.00% |